Clinical Trials Browser

Neoplasms × Sorafenib × Dermatologic × Clear all

NCT00110994 2015-06-08

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Phase 2 Completed

101 enrolled 21 charts

Melanoma, Neoplasms

NCT00827177 2014-01-24

Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Neoplasms